Rhythm Pharmaceuticals, Inc. (RYTM)
RYTM price $88.81 -1.39 -1.54%
- Ticker
- RYTM
- Price
- $88.81
- Change
- -1.39 -1.54%
- Market cap
- $6.11B
- P/E
- -29.00
- Forward P/E
- 34.04
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 61
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in…